These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23547854)

  • 21. Pregabalin: dose-response relationship in generalized anxiety disorder.
    Boschen MJ
    Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice.
    Bobes J; Rubio G; Terán A; Cervera G; López-Gómez V; Vilardaga I; Pérez M
    Eur Psychiatry; 2012 May; 27(4):301-7. PubMed ID: 21334859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin in benzodiazepine withdrawal.
    Biermann T; Bleich S; Kornhuber J; Hillemacher T
    Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
    [No Abstract]   [Full Text] [Related]  

  • 24. Marijuana use from adolescence to adulthood: developmental trajectories and their outcomes.
    Brook JS; Zhang C; Leukefeld CG; Brook DW
    Soc Psychiatry Psychiatr Epidemiol; 2016 Oct; 51(10):1405-1415. PubMed ID: 27168181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A content analysis of personal strivings: associations with substance use.
    Simons JS; Christopher MS; Oliver MN; Stanage EJ
    Addict Behav; 2006 Jul; 31(7):1224-30. PubMed ID: 16246493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregabalin-associated elevation of clozapine serum levels.
    Gahr M; Schmid MM; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2012 Nov; 45(7):297-9. PubMed ID: 22473300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin abuse and dependence in Germany: results from a database query.
    Gahr M; Freudenmann RW; Hiemke C; Kölle MA; Schönfeldt-Lecuona C
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1335-42. PubMed ID: 23292158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in primary care settings.
    Low NC; Lee SS; Johnson JG; Williams JB; Harris ES
    Fam Pract; 2008 Oct; 25(5):321-7. PubMed ID: 18753288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat.
    Stopponi S; Somaini L; Cippitelli A; de Guglielmo G; Kallupi M; Cannella N; Gerra G; Massi M; Ciccocioppo R
    Psychopharmacology (Berl); 2012 Mar; 220(1):87-96. PubMed ID: 21887495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of social phobia and general anxiety with alcohol and drug use in a community sample of adolescents.
    Fröjd S; Ranta K; Kaltiala-Heino R; Marttunen M
    Alcohol Alcohol; 2011; 46(2):192-9. PubMed ID: 21245062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis Addiction and the Brain: a Review.
    Zehra A; Burns J; Liu CK; Manza P; Wiers CE; Volkow ND; Wang GJ
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):438-452. PubMed ID: 29556883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin-induced suicidal ideations.
    Mutschler J; Grosshans M; Herwig U; Heekeren K; Kawohl W; Brühl A
    Pharmacopsychiatry; 2011 May; 44(3):119. PubMed ID: 21318939
    [No Abstract]   [Full Text] [Related]  

  • 36. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
    Bech P
    Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of adults seeking medical marijuana certification.
    Ilgen MA; Bohnert K; Kleinberg F; Jannausch M; Bohnert AS; Walton M; Blow FC
    Drug Alcohol Depend; 2013 Oct; 132(3):654-9. PubMed ID: 23683791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.